147 related articles for article (PubMed ID: 34935404)
21. Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines.
Brown A; Shah S; Dluzewski S; Musaddaq B; Wagner T; Szyszko T; Wan S; Groves A; Mokbel K; Malhotra A
Clin Radiol; 2021 Aug; 76(8):553-558. PubMed ID: 34053731
[TBL] [Abstract][Full Text] [Related]
22. Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation.
Igual-Rouilleault AC; Soriano I; Quan PL; Fernández-Montero A; Elizalde A; Pina L
Eur Radiol; 2022 May; 32(5):3199-3206. PubMed ID: 34655312
[TBL] [Abstract][Full Text] [Related]
23. Limiting Screening Mammography Recalls for Vaccine-Induced Adenopathy, a Single Institution Experience.
Maimone S; Robinson KA; Advani PP; Li Z; Gococo-Benore DA; Qosja N; Ashai AM; Mummareddy A; Chumsri S
Acad Radiol; 2022 Oct; 29(10):1480-1485. PubMed ID: 35090829
[TBL] [Abstract][Full Text] [Related]
24. Analysis of clinical factors and ultrasound features associated with COVID-19 vaccine-related axillary lymphadenopathy: A large group study.
Lim J; Khil EK; Lee SA; Choi JA; Lee KY; Jo SW; Lee J
Clin Imaging; 2024 Jan; 105():110046. PubMed ID: 38039749
[TBL] [Abstract][Full Text] [Related]
25. Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma.
Ashoor A; Shephard J; Lissidini G; Nicosia L
Korean J Radiol; 2022 Jul; 23(7):775-776. PubMed ID: 35695318
[No Abstract] [Full Text] [Related]
26. Ultrasound Features to Differentiate COVID-19 Vaccine-Induced Benign Adenopathy from Breast Cancer Related Malignant Adenopathy.
Hl C; Gj W; Jwt L; J S; Lp M; Ht LP
Acad Radiol; 2022 Jul; 29(7):1004-1012. PubMed ID: 35296413
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 vaccine-induced lymphadenopathies: incidence, course and imaging features from an ultrasound prospective study.
Romeo V; Stanzione A; D'Auria D; Fulgione L; Giusto F; Maurea S; Brunetti A
J Ultrasound; 2022 Dec; 25(4):965-971. PubMed ID: 35507248
[TBL] [Abstract][Full Text] [Related]
28. The Canadian Society of Breast Imaging Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination - Update.
Seely JM; Barry MH
Can Assoc Radiol J; 2021 Nov; 72(4):601-602. PubMed ID: 33622040
[No Abstract] [Full Text] [Related]
29. COVID-19 vaccine-related unilateral axillary lymphadenopathy: Pattern on screening breast MRI allowing for a benign assessment.
Plaza MJ; Wright J; Fernandez S
Clin Imaging; 2021 Dec; 80():139-141. PubMed ID: 34325221
[No Abstract] [Full Text] [Related]
30. Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible.
Finsterer J
Korean J Radiol; 2022 Jul; 23(7):773-774. PubMed ID: 35695321
[No Abstract] [Full Text] [Related]
31. Frequency of Ipsilateral Axillary Lymphadenopathy After the Inactivated COVID-19 Vaccine.
Turan A; Kaplanoğlu H; Kaplanoğlu V
Curr Med Imaging; 2022; 18(11):1214-1221. PubMed ID: 35272599
[TBL] [Abstract][Full Text] [Related]
32. Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: comment.
Kleebayoon A; Wiwanitkit V
Radiol Med; 2023 Dec; 128(12):1593-1594. PubMed ID: 37962776
[No Abstract] [Full Text] [Related]
33. COVID-19 vaccine associated axillary lymphadenopathy - A systematic review.
Co M; Wong PCP; Kwong A
Cancer Treat Res Commun; 2022; 31():100546. PubMed ID: 35334408
[TBL] [Abstract][Full Text] [Related]
34. Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging:
Becker AS; Perez-Johnston R; Chikarmane SA; Chen MM; El Homsi M; Feigin KN; Gallagher KM; Hanna EY; Hicks M; Ilica AT; Mayer EL; Shinagare AB; Yeh R; Mayerhoefer ME; Hricak H; Vargas HA
Radiology; 2021 Aug; 300(2):E323-E327. PubMed ID: 33625298
[TBL] [Abstract][Full Text] [Related]
35. Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.
Garreffa E; Hamad A; O'Sullivan CC; Hazim AZ; York J; Puri S; Turnbull A; Robertson JF; Goetz MP
Eur J Cancer; 2021 Dec; 159():38-51. PubMed ID: 34731748
[TBL] [Abstract][Full Text] [Related]
36. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
[TBL] [Abstract][Full Text] [Related]
37. Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review.
Keshavarz P; Yazdanpanah F; Rafiee F; Mizandari M
Acad Radiol; 2021 Aug; 28(8):1058-1071. PubMed ID: 33985872
[TBL] [Abstract][Full Text] [Related]
38. Follow-up of COVID-19 Vaccine-related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary.
Moy L; Kim E
Radiology; 2022 Oct; 305(1):54-55. PubMed ID: 35471114
[No Abstract] [Full Text] [Related]
39. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
40. Re: Unilateral axillary adenopathy in the setting of COVID-19 vaccine, Clinical Imaging, January 2021.
Finnegan J; Govender P; Torreggiani WC
Clin Imaging; 2021 Jul; 75():171-172. PubMed ID: 33838977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
